StockData
Lifevantage Corp logo

Lifevantage Corp (LFVN) stock

LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 20/3043% below fair value
$4.81+0.03 (+0.63%)

Close on Nov 18, 2026Market cap $60.26MP/E 12.0Yield 3.85%

Lifevantage shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Lifevantage's shares outstanding was 13M at Jun 30, 2026. For fiscal 2026 it was 13M, down 2.2% from the year before. Over ten years it grew -1.3% a year on average. The highest annual figure on record is 18M in fiscal 2013.

Annual shares outstanding

PeriodPeriod endValueChange
FY2026Jun 30, 202613M-2.2%
FY2025Jun 30, 202513M+0.0%
FY2024Jun 30, 202413M+3.3%
FY2023Jun 30, 202313M-3.8%
FY2022Jun 30, 202213M-8.4%
FY2021Jun 30, 202114M-2.3%
FY2020Jun 30, 202015M-2.5%
FY2019Jun 30, 201915M+6.0%
FY2018Jun 30, 201814M+0.1%
FY2017Jun 30, 201714M-2.8%
FY2016Jun 30, 201615M+2.7%
FY2015Jun 30, 201514M-11.2%
FY2014Jun 30, 201416M-9.2%
FY2013Jun 30, 201318M+3.9%
FY2012Jun 30, 201217M+61.7%
FY2011Jun 30, 201110M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 202613M-3.5%
Q3 FY2026CQ1 2026Mar 31, 202613M-4.8%
Q2 FY2026CQ4 2025Dec 31, 202513M-3.3%
Q1 FY2026CQ3 2025Sep 30, 202513M+1.0%
Q4 FY2025CQ2 2025Jun 30, 202513M+0.6%
Q3 FY2025CQ1 2025Mar 31, 202513M+2.4%
Q2 FY2025CQ4 2024Dec 31, 202413M+4.5%
Q1 FY2025CQ3 2024Sep 30, 202413M-2.2%
Q4 FY2024CQ2 2024Jun 30, 202413M+2.5%
Q3 FY2024CQ1 2024Mar 31, 202413M+1.7%
Q2 FY2024CQ4 2023Dec 31, 202313M+0.6%
Q1 FY2024CQ3 2023Sep 30, 202313M+4.9%
Q4 FY2023CQ2 2023Jun 30, 202313M+2.1%
Q3 FY2023CQ1 2023Mar 31, 202313M-3.7%
Q2 FY2023CQ4 2022Dec 31, 202213M-5.6%
Q1 FY2023CQ3 2022Sep 30, 202212M-7.2%
Q4 FY2022CQ2 2022Jun 30, 202212M-10.7%
Q3 FY2022CQ1 2022Mar 31, 202213M-6.7%
Q2 FY2022CQ4 2021Dec 31, 202113M-8.0%
Q1 FY2022CQ3 2021Sep 30, 202113M-8.3%
Q4 FY2021CQ2 2021Jun 30, 202114M-5.5%
Q3 FY2021CQ1 2021Mar 31, 202114M-3.2%
Q2 FY2021CQ4 2020Dec 31, 202014M-0.8%
Q1 FY2021CQ3 2020Sep 30, 202015M-2.7%
Q4 FY2020CQ2 2020Jun 30, 202015M-2.4%
Q3 FY2020CQ1 2020Mar 31, 202015M-3.9%
Q2 FY2020CQ4 2019Dec 31, 201915M-2.7%
Q1 FY2020CQ3 2019Sep 30, 201915M-0.2%
Q4 FY2019CQ2 2019Jun 30, 201915M+6.0%
Q3 FY2019CQ1 2019Mar 31, 201915M+7.8%
Q2 FY2019CQ4 2018Dec 31, 201815M+5.7%
Q1 FY2019CQ3 2018Sep 30, 201815M+7.5%
Q4 FY2018CQ2 2018Jun 30, 201814M+0.2%
Q3 FY2018CQ1 2018Mar 31, 201814M+0.5%
Q2 FY2018CQ4 2017Dec 31, 201714M+0.1%
Q1 FY2018CQ3 2017Sep 30, 201714M-2.7%
Q4 FY2017CQ2 2017Jun 30, 201714M–
Q3 FY2017CQ1 2017Mar 31, 201714M–
Q2 FY2017CQ4 2016Dec 31, 201614M–
Q1 FY2017CQ3 2016Sep 30, 201614M–

More Lifevantage figures

See a number that looks wrong?